Evaluation of optimal regimens for treatment of rifampicin resistant-tuberculosis: Multicenter, randomized controlled study in China

被引：0
作者：
Tang, Shenjie [1 ]
Yao, Lan [1 ]
Hao, Xiaohui [1 ]
Liu, Yidian [1 ]
机构：
[1] Capital Med Univ, Beijing Chest Hosp, TB Multidisciplinary Diag & Treatment Ctr, Beijing, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Tuberculosis; -; management; Treatments; MDR-TB;
D O I：
10.1183/13993003.congress-2015.PA3341
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3341
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
    Tang, Shenjie
    Yao, Lan
    Hao, Xiaohui
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [2] Clofazimine For The Treatment Of Multidrug-Resistant Tuberculosis: Multicenter, Randomized Controlled Study
    Tang, S.
    Hao, X.
    Yao, L.
    Liu, Y.
    Sun, H.
    Gu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [3] Clofazimine For The Treatment Of Multidrug-Resistant Tuberculosis: Multicenter, Randomized Controlled Study
    Tang, S.
    Hao, X.
    Yao, L.
    Liu, Y.
    Sun, H.
    Gu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [4] Clofazimine for the treatment of multidrug-resistant tuberculosis: Multicenter, randomized controlled study
    Tang, Shenjie
    Hao, Xiaohui
    Yao, Lan
    Liu, Yidian
    Sun, Hua
    Gu, Jin
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Twenty-four-week interim outcomes of bedaquiline-containing regimens in treatment of adolescents with rifampicin-resistant tuberculosis: A retrospective cohort study in China
    Wu, Hao-Yu
    Tian, Yao
    Wang, Xiao-Dan
    Sun, Ji-Si
    Fan, Li-Chao
    Chen, Mo-Xin
    Li, Ran
    Chen, Yu
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (01) : 116 - 121
  • [6] Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis
    Farley, J. E.
    McKenzie-White, J.
    Bollinger, R.
    Hong, H.
    Lowensen, K.
    Chang, L. W.
    Stamper, P.
    Berrie, L.
    Olsen, F.
    Isherwood, L.
    Ndjeka, N.
    Stevens, W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (09) : 980 - +
  • [7] Incidence, types and predictors of adverse events and their impact on treatment outcomes in multidrug/rifampicin resistant tuberculosis patients receiving all oral treatment regimens
    Shah, Sayed Idrees
    Ghafoor, Abdul
    Rahman, Shafiq Ur
    Abidullah, Nafees
    Ahmad, Nafees
    Al-Qaaneh, Ayman M.
    Younis, Faisal
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2024,
  • [8] Resistant Hypertension Optimal Treatment Trial: A Randomized Controlled Trial
    Krieger, Eduardo M.
    Drager, Luciano F.
    Artigas Giorgi, Dante Marcelo
    Krieger, Jose Eduardo
    Pereira, Alexandre Costa
    Soares Barreto-Filho, Jose Augusto
    Nogueira, Armando da Rocha
    Mill, Jose Geraldo
    CLINICAL CARDIOLOGY, 2014, 37 (01) : 1 - 6
  • [9] A highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis: a multicenter prospective study in China
    Sun, Wenwen
    Wu, Zheyuan
    Zhou, Ying
    Xia, Fan
    Tang, Qin
    Wang, Jie
    Yang, Jinghui
    Yu, Fangyou
    Yang, Hua
    Xiao, Heping
    Fan, Lin
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [10] A highly effective and inexpensive standardized treatment of multidrug-resistant tuberculosis: a multicenter prospective study in China
    Wenwen Sun
    Zheyuan Wu
    Ying Zhou
    Fan Xia
    Qin Tang
    Jie Wang
    Jinghui Yang
    Fangyou Yu
    Hua Yang
    Heping Xiao
    Lin Fan
    BMC Infectious Diseases, 21
12345